Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Source/Isolation  





2 Biochemistry  





3 Target  





4 Mode of Action  





5 Toxicity  





6 References  














BmTx3







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


BmTx3 is a neurotoxin, which is a component of the venom of the scorpion Buthus Martensi Karsch. It blocks A-type potassium channels in the central nervous system and hERG-channels in the heart.

Source/Isolation[edit]

BmTx3 was originally purified from the venom of the Chinese scorpion, Buthus Martensi Karsch. BmTx3 is a “short-chain” peptide like other potassium channel blockers in the scorpion venom and added to the phylogenetic tree in the subfamily α-KTx15. Its 3D structure has not yet been elucidated, but based on sequence similarity it likely resembles the 3D structure of BmTx1 [1]orDiscrepin.[2]

Biochemistry[edit]

BmTx3 consists of an α-helix and two β-sheet segments cross-linked by three disulfide bridges (Cs-α/β motif).[1] It is a short chain peptide with a molecular mass of 3751.6 Da; it consists of 37 amino acids.[1]

α/β motif of BmTx3

Target[edit]

BmTx3 is the first toxin from the scorpion α-KTx subfamily 15 [3] with two functional faces. As all α-KTx peptides, BmTx3 blocks A-type (IA) potassium currents (KD = 54 nM). BmTx3 blocks primarily the Kv4.x proteins and has a higher affinity for Kv4.1 channels than for Kv4.2 and Kv4.3 channels.[4] The second functional face of BmTx3 blocks the hERG (human Ether-à-go-go) channel (KD = 2 μM), a characteristic belonging to γ-KTx peptides.[4] BmTx3 binding site seems essentially localized in neurons but could also be present in glial cells, endothelial cells and/or arterial smooth muscle cells. The distribution of BmTx3 binding sites is heterogeneous; a high density is found in the caudateputamen and accumbens nucleus, thalamus, hippocampal formation and cerebellum.[4]

Mode of Action[edit]

The functional face of “short-chain” scorpion toxins is built of two important dyads (Lys and Tyr) on the β-sheet side. Lysine plugs deep into the channel pore and Tyrosine, as penultimate or ultimate and hydrophobic residue, turns it to fixate it, leading to a physical occlusion of the channel pore.[1] This is supported by the finding that deletion of the two C-terminal residues (sBmTx3-delYP) results in loss of ability to block IA-current.[1]

The other functional face is thought to be situated at the α-helix-side and composed of Arg18 and Lys19, like the functional face of other hERG toxins. It is known that α-KTx peptides use the β-sheet side to interact with the receptor, whereas γ-KTx peptides usually use their α-helix-side.[5] As BmTx3 seems to use both sides to bind to different potassium channels, it might be an evolutionary transient between the two families.[5]

Toxicity[edit]

When injected into mice it causes epileptiform behavior.[6] This might be due to its effect on A-type K+ channels, which, like the Kv4.x, are involved in action potential back propagation, firing frequency, spike initiation and action potential waveform determination.[4] Blocking of the hERG channel can cause drug-induced long QT syndrome, arrhythmias and ventricular fibrillation which can result in death.[5]

References[edit]

  1. ^ a b c d e Vacher, H. (2003). "Functional consequences of deleting the two C-terminal residues of the scorpion toxin BmTX3". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1646 (1–2): 152–156. doi:10.1016/S1570-9639(02)00557-5. PMID 12637022.
  • ^ Prestipino, G. (2009). "Scorpion toxins that block transient currents (I(A)) of rat cerebellum granular cells". Toxicology Letters. 187 (1): 1–9. doi:10.1016/j.toxlet.2009.01.027. PMID 19429236.
  • ^ Vacher, H. (2004). "Definition of the alpha-KTx15 subfamily". Toxicon. 43 (8): 887–94. doi:10.1016/j.toxicon.2004.03.023. PMID 15208021.
  • ^ a b c d Vacher, H. (2006). "Kv4 channels sensitive to BmTX3 in rat nervous system: autoradiographic analysis of their distribution during brain ontogenesis". Eur J Neurosci. 24 (5): 1325–40. doi:10.1111/j.1460-9568.2006.05020.x. PMID 16987219. S2CID 3129580.
  • ^ a b c Huys, I. (2004). "BmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currents". Biochem. J. 378 (Pt 3): 745–52. doi:10.1042/BJ20031324. PMC 1223995. PMID 14599291.
  • ^ Vacher, H. (2001). "A new class of scorpion toxin binding sites related to an A-type K+ channel: pharmacological characterization and localization in rat brain". FEBS Lett. 501 (1): 31–5. doi:10.1016/S0014-5793(01)02620-5. PMID 11457451.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=BmTx3&oldid=1136548415"

    Categories: 
    Neurotoxins
    Ion channel toxins
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
     



    This page was last edited on 30 January 2023, at 22:09 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki